LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

Search

Avanos Medical Inc

Slēgts

SektorsVeselības aprūpe

12.13 0.66

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

12.03

Max

12.19

Galvenie mērījumi

By Trading Economics

Ienākumi

5.8M

6.6M

Pārdošana

-12M

168M

P/E

Sektora vidējais

33.255

50.857

EPS

0.141

Peļņas marža

3.94

Darbinieki

2,227

EBITDA

428M

21M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+15.89% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 30. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-205M

560M

Iepriekšējā atvēršanas cena

11.47

Iepriekšējā slēgšanas cena

12.13

Ziņu noskaņojums

By Acuity

100%

0%

368 / 381 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

Avanos Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 20. jūn. 18:52 UTC

Peļņas

Accenture Shares Fall on Bookings Decline, Concerns over Federal Government Contract -- 3rd Update

2025. g. 20. jūn. 16:15 UTC

Iegādes, apvienošanās, pārņemšana

Canadian Natural Selling Control of Gas Plant to Secure Approval for Schlumberger Deal

2025. g. 20. jūn. 20:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Financial Services Roundup: Market Talk

2025. g. 20. jūn. 20:50 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 20. jūn. 20:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 20. jūn. 20:13 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Moved the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

2025. g. 20. jūn. 20:11 UTC

Tirgus saruna

Natural Gas Slides in Late-Week Profit Taking -- Market Talk

2025. g. 20. jūn. 19:56 UTC

Tirgus saruna

Crude Oil Slips to End Week -- Market Talk

2025. g. 20. jūn. 18:35 UTC

Tirgus saruna

Warehouse Clubs Seen Growing Market Share -- Market Talk

2025. g. 20. jūn. 18:12 UTC

Tirgus saruna

Gold Slides to Close Shortened Week -- Market Talk

2025. g. 20. jūn. 17:56 UTC

Tirgus saruna

Baker Hughes Reports Slight Decrease in U.S. Rig Count -- Market Talk

2025. g. 20. jūn. 17:50 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

2025. g. 20. jūn. 17:35 UTC

Iegādes, apvienošanās, pārņemšana

Cisco Was the Dot-Com Bust's Biggest Loser. Now It's at a 25-Year High. -- Barrons.com

2025. g. 20. jūn. 17:30 UTC

Tirgus saruna
Peļņas

Adobe's AI Headwinds Seen Fading -- Market Talk

2025. g. 20. jūn. 17:03 UTC

Peļņas

Accenture Earnings Beat Expectations. Why the Stock Is Falling Anyway. -- Barrons.com

2025. g. 20. jūn. 16:50 UTC

Tirgus saruna
Peļņas

Global Equities Roundup: Market Talk

2025. g. 20. jūn. 16:50 UTC

Tirgus saruna
Peļņas

Accenture Seeing Companies Shift to Leapfrog Mentality -- Market Talk

2025. g. 20. jūn. 16:44 UTC

Iegādes, apvienošanās, pārņemšana

Meet QXO, the Upstart Building Materials Stock That May Battle Home Depot for GMS -- Barrons.com

2025. g. 20. jūn. 16:40 UTC

Tirgus saruna
Peļņas

Accenture Can't Yet Estimate Longer Term Impact from Federal Cuts -- Market Talk

2025. g. 20. jūn. 16:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Financial Services Roundup: Market Talk

2025. g. 20. jūn. 16:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 20. jūn. 16:17 UTC

Iegādes, apvienošanās, pārņemšana

UniCredit: ULI and UVA Are Expected to Merge in 2026

2025. g. 20. jūn. 16:17 UTC

Iegādes, apvienošanās, pārņemšana

UniCredit: Alessandro Santoliquido has been appointed CEO of both companies alongside his role as Head of Group Insurance

2025. g. 20. jūn. 16:05 UTC

Tirgus saruna

Gold Futures on Track to End Week Lower Despite Haven Demand -- Market Talk

2025. g. 20. jūn. 15:56 UTC

Tirgus saruna
Peļņas

Accenture Says Federal Business Had Immaterial Impact to Growth -- Market Talk

2025. g. 20. jūn. 15:26 UTC

Tirgus saruna

Natural Gas Slips After Streak of Higher Closes -- Market Talk

2025. g. 20. jūn. 15:25 UTC

Iegādes, apvienošanās, pārņemšana

Regulator Says Satisfied Sale Would Preserve Competition in Area Around Seiu Processing Plant

2025. g. 20. jūn. 15:25 UTC

Iegādes, apvienošanās, pārņemšana

Competition Bureau Says Canadian Natural to Sell 75% Stake in Seiu Lake Natural Gas Plant to North 40 Resources

2025. g. 20. jūn. 15:25 UTC

Iegādes, apvienošanās, pārņemšana

Canada Antitrust Regulation Reaches Agreement With Canadian Natural Resources Over Proposed Buy of Schlumberger JV Interest

2025. g. 20. jūn. 15:09 UTC

Tirgus saruna

Canadian Retail Sales Show Reversal of Tariff Front-Running -- Market Talk

Salīdzinājums

Cenas izmaiņa

Avanos Medical Inc Prognoze

Cenas mērķis

By TipRanks

15.89% augšup

Prognoze 12 mēnešiem

Vidējais 14 USD  15.89%

Augstākais 14 USD

Zemākais 14 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Avanos Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

2 ratings

0

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

12.28 / 12.71Atbalsts un pretestība

Īstermiņā

Very Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

368 / 381 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.